[Federal Register Volume 85, Number 39 (Thursday, February 27, 2020)]
[Notices]
[Page 11376]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-03941]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel PAR Panel; Cancer Health Disparities.
    Date: March 23-24, 2020.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Ola Mae Zack Howard, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4192, MSC 7806, Bethesda, MD 
20892, 301-451-4467, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Small Business; Cancer Drug Development and Therapeutics.
    Date: March 23-24, 2020.
    Time: 8:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Canopy by Hilton, 940 Rose Avenue, North Bethesda, MD 
20852.
    Contact Person: Lilia Topol, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 20892, 301-451-
0131, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel PAR Panel; Alzheimer Disease Research.
    Date: March 23, 2020.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Dr., Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Andrew Louden, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3137, Bethesda, MD 20817, 301-435-1985, 
[email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel PAR Panel; Mammalian Models for Translation Research.
    Date: March 23, 2020.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Malaya Chatterjee, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 6192, MSC 7804, Bethesda, MD 
20892, 301-806-2515, [email protected].

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Perception and Cognition Research to Inform Cancer Image 
Interpretation.
    Date: March 23, 2020.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Dr., Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Devon Rene Brost Oskvig, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3172, Bethesda, MD 20892, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 21, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-03941 Filed 2-26-20; 8:45 am]
 BILLING CODE 4140-01-P